We previously observed reduced Th22 percentage in the probiotics group at 3 months. However, since the effect was not seen earlier and did not last, it may not be the main reason for AD prevention.
Zakiudin et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: